Search
for
Sort by
Research 121–150 of 1000+
- Extracellular vesicles as precision therapeutics for psychiatric conditions: targeting interactions among neuronal, glial, and immune networks
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Polymer- and Lipid-Based Nanostructures for Wound Healing with Barrier-Resolved Design
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond
- Direct Vasodilators and Sympatholytic Agents
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
- A Case of Contact Allergic Dermatitis to Topical Minoxidil
- Oral Lichen Planus
- Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications
- Knowledge and beliefs about the use/abuse of oral contraceptive pills among males: A mixed-method explanatory sequential study in community pharmacy settings
- Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- New-Onset Alopecia Is Significantly Higher with Tirzepatide than with Semaglutide, Even After Weight-Loss Matching
- Comparative efficacy and safety of platelet-rich plasma (PRP), injectable platelet-rich fibrin (i-PRF) and concentrated growth factors (CGF) for female pattern hair loss (FPHL): a prospective multicenter randomized clinical trial
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Minimally Invasive Non-Surgical Therapies for Androgenetic Alopecia: A Narrative Review of Clinical Evidence for Regenerative and Locally Acting Antiandrogen Treatments
- Regenerative Strategies for Androgenetic Alopecia: Evidence, Mechanisms, and Translational Pathways
- Microneedling for Androgenetic Alopecia: A Synergistic Strategy Enhancing Drug Delivery and Follicular Regeneration
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Repurposed Drugs: Current Trends in Drug Discovery
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome